News / Health

New Therapy for Peanut Allergy Shows Promise

Similar to allergy shots for dust and pollen, feeding peanuts in tiny amounts is designed to reprogram the young patients’ immune system so peanuts don’t provoke life-threatening reactions.
Similar to allergy shots for dust and pollen, feeding peanuts in tiny amounts is designed to reprogram the young patients’ immune system so peanuts don’t provoke life-threatening reactions.
Jessica Berman
To someone with a peanut allergy, accidentally ingesting a product containing even tiny amounts of the legume can trigger a potentially life-threatening reaction.  But researchers have found that when patients were given miniscule daily doses of peanut powder, they were able to build tolerance to the deadly food allergen.  
 
There is currently no allergy shot to desensitize individuals with a peanut allergy. The best treatment is to avoid all foods that might contain peanuts, which - in some people - can cause a potentially fatal reaction called anaphylaxis, in which the airways tighten and restrict breathing.  The only treatment is a rescue shot of epinephrine, which opens the airways. Those with the allergy often carry an emergency shot with them.
 
It might seem dangerous to give these people an oral dose of peanut powder.  But that’s exactly what U.S. researchers did in a new multi-center clinical trial. 
 
Wesley Burks, chairman of the department of pediatrics at the University of North Carolina School of Medicine in Chapel Hill, led the study.  He says 20 peanut-sensitive adolescents at two centers were given liquid containing miniscule amounts of peanut powder which they held under their tongue for two minutes before swallowing, while 20 received a placebo, or inactive, liquid. 
 
Every day, according to Burks, scientists increased the amount of peanut in the liquid by a tiny fraction.
 
“Before the study, they only could eat a third of a peanut.  At the end of the study they could tolerate three peanuts.  So that difference changed.  What we don’t know is how long do you need to continue the therapy and then you need to stop it so that change is permanent," he said. 
 
More studies will be conducted to find that out.  The SLIT trial, which stands for Sub-Lingual or beneath-the-tongue Immuno-Therapy, shows promise in desensitizing people with severe peanut allergies; after 44 weeks, adolescents in the study could tolerate ten times as much peanut as before the trial, compared to subjects who received an inactive liquid, according to Burks. 
 
The researcher cautions those with peanut allergies not to try desensitizing themselves.  Microdoses measured in just billionths of a gram of peanut power were used in the trial, doses that could not be replicated at home.
 
"We were unbelievably safe in trying to administer the product.  And it is not something that's ready for practice or ready for home use, because for peanut-allergic patients, there's too many dangers in doing that," he said. 
 
The study on treating peanut allergy with sublingual therapy is published in the Journal of Allergy and Clinical Immunology.

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid